Avalyn Pharma Inc Balance Sheet
Avalyn Pharma Inc's total assets for Q2 2026 were $425.45M, an increase of 213.61% from the previous quarter. AVLN total liabilities were $27.10M for the fiscal quarter, a -93.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
